Forward PE Ratio: 15.56
The forward PE ratio is 15.56 as of Thursday, July 9, 2026.
Forward PE Ratio (15.56) = Close Price ($83.86) / Consensus Forward EPS ($5.35)
HSIC Forward PE Ratio Metrics
FORWARD PE RATIO
15.56
HSIC Competitors' Forward PE Ratio
Henry Schein, Inc.
Market Cap
$9.55B
Forward PE Ratio
15.56
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Henry Schein, Inc. (HSIC) | $9.55B | 15.56 |
| Universal Health Services, Inc. (UHS)vs › | $9.72B | 6.66 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 7.65 |
| Tempus AI, Inc. (TEM)vs › | $10.73B | N/A |
| Insulet Corp. (PODD)vs › | $10.96B | 24.29 |
| Oscar Health, Inc. (OSCR)vs › | $8.09B | 29.55 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.04B | 31.40 |
| Bio-Techne Corporation (TECH)vs › | $11.14B | 36.89 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | N/A |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.25B | 20.18 |
Trailing vs Forward
Trailing P/E
25.1
reported TTM EPS
Forward P/E
15.6
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $5.35 implies +61.6% EPS growth vs the reported trailing $3.31.
Forward P/E by Fiscal Year
View All Analyst EstimatesAt today's $83.86 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-27 | $5.35 | $5.28 – $5.38 | 10 | 15.7x |
| 2027-12-27 | $5.92 | $5.83 – $6.13 | 10 | 14.2x |
| 2028-12-27 | $6.51 | $5.71 – $7.03 | 6 | 12.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
Forward PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Forward PE Ratio FAQ
- What is the forward PE ratio for Henry Schein, Inc. (HSIC)?
- The forward PE ratio for HSIC stock is 15.56.
Related Metrics
About Henry Schein, Inc.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Andrea Albertini